Pseudomonas aeruginosa

From Aaushi
Jump to navigation Jump to search

Etiology

risk factors

Epidemiology

Pathology

Clinical manifestations

Laboratory

Radiology

Complications

Management

More general terms

Additional terms

References

  1. Manual of Medical Therapeutics, 28th edition, Ewald & McKenzie (eds) Little, Brown & Co, 1995, pg 301
  2. Harrison's Principles of Internal Medicine, 13th ed. Companion Handbook, Isselbacher et al (eds), McGraw-Hill Inc. NY, 1995, pg 227-228
  3. Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 797
  4. Jump up to: 4.0 4.1 4.2 Journal Watch 21(17):140, 2001 Fiorillo L et al The pseudomonas hot-foot syndrome. N Engl J Med 345:335, 2001 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11484690
  5. Jump up to: 5.0 5.1 5.2 5.3 Medical Knowledge Self Assessment Program (MKSAP) 15, 16, 17, 18. American College of Physicians, Philadelphia 2009, 2012, 2015, 2018
  6. Jump up to: 6.0 6.1 6.2 Pogue JM, Marchaim D, Kaye D, Kaye KS. Revisiting "older" antimicrobials in the era of multidrug resistance. Pharmacotherapy. 2011 Sep;31(9):912-21 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21923592
  7. Cilloniz C, Gabarrus A, Ferrer M et al Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug- Resistant Pseudomonas aeruginosa. Chest. 2016 Aug;150(2):415-25. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27060725
  8. Jump up to: 8.0 8.1 8.2 8.3 Elkston CA, Elkston DM Bacterial Skin Infections: More Than Skin Deep. Medscape. July 19, 2021 https://reference.medscape.com/slideshow/infect-skin-6003449
  9. Jump up to: 9.0 9.1 NEJM Knowledge+
  10. Jump up to: 10.0 10.1 10.2 Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA. Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. Clin Infect Dis. 2024 Aug 7:ciae403. PMID: https://www.ncbi.nlm.nih.gov/pubmed/39108079 https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciae403/7728556
  11. Ibrahim D, Jabbour JF, Kanj SS. Current choices of antibiotic treatment for Pseudomonas aeruginosa infections. Curr Opin Infect Dis. 2020;33:464-473. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33148986
  12. Jump up to: 12.0 12.1 12.2 Bavaro DF et al. Antipseudomonal cephalosporins versus piperacillin/tazobactam or carbapenems for the definitive antibiotic treatment of Pseudomonas aeruginosa bacteraemia: New kids on the ICU block? J Antimicrob Chemother 2025 Mar 15; PMID: https://www.ncbi.nlm.nih.gov/pubmed/40088112 https://academic.oup.com/jac/advance-article-abstract/doi/10.1093/jac/dkaf080/8078947